# AstraZeneca AB – FDA Inspection, Apr 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-ab/45e505d2-6072-4063-8327-80b89d82e448
Source feed: FDA_Inspections

> FDA inspection 1318264 of AstraZeneca AB, April 10, 2026. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1318264
- Company Name: AstraZeneca AB
- Inspection Date: 2026-04-10
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1295446 - 2025-11-13
- [FDA Inspection 1248230 - 2022-12-01](https://www.keypedia.com/records/fda_inspections/astrazeneca-ab/27c718fa-7c43-4bb4-8673-10c7d64f0095)
- FDA Inspection 1143443 - 2019-12-06
- [FDA Inspection 1068727 - 2018-10-11](https://www.keypedia.com/records/fda_inspections/astrazeneca-ab/d9816a7a-79d6-44ef-a9a7-a7fd466d76ee)
- FDA Inspection 1115572 - 2017-12-07

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/allison-a-aldridge/bdf1154e-481c-4229-b720-c1261af9bcb7)
- [Issuing Officer](https://www.keypedia.com/people/rowena-s-nguyen/ae39318e-1653-467c-94cc-26f8929441ac)

Company: https://www.keypedia.com/companies/astrazeneca-ab/b85a1aa5-9a0c-4c1e-996d-70b40b2507de

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8